Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IDIOPATHIC PARKINSON'S DISEASE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00243971
What this trial is testing

A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma
Not applicableLooking for participantsNCT05539196
What this trial is testing

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Who this might be right for
Movement DisordersNeurologyParkinsons Disease
InSightec 60
Testing effectiveness (Phase 2)Study completedNCT01211587
What this trial is testing

A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease

Who this might be right for
Parkinson's Disease With Cognitive Impairments
Newron Pharmaceuticals SPA 103
Post-approval studies (Phase 4)Ended earlyNCT00642356
What this trial is testing

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

Who this might be right for
Parkinson's Disease
Novartis 14
Not applicableNot Yet RecruitingNCT07813156
What this trial is testing

Idiopathic Parkinson's Disease: Interest of an Early Group-Based Cognitive Rehabilitation Program (LIFECOG-PD)

Who this might be right for
Parkinson Disease (PD)
University Hospital, Clermont-Ferrand 24
Not applicableEnrolling By InvitationNCT07698236
What this trial is testing

Temporal Interference Noninvasive Deep Brain Stimulation for Idiopathic Parkinson's Disease and Parkinsonian Syndromes: Effects and Target Exploration

Who this might be right for
Parkinson's DiseaseParkinsonian Syndromes
Ruijin Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT02453386
What this trial is testing

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients

Who this might be right for
Idiopathic Parkinson's Disease
Biotie Therapies Inc. 449
Not applicableStudy completedNCT05107531
What this trial is testing

Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing

Who this might be right for
Idiopathic Parkinson's Disease
Hacettepe University 30
Not applicableStudy completedNCT00664157
What this trial is testing

Facial Expression Recognition of Emotion and Categorization of Emotional Words in Parkinson's Disease. Impact of L-Dopa and Deep Brain Stimulation of Subthalamic Nucleus

Who this might be right for
Idiopathic Parkinson's Disease
University Hospital, Clermont-Ferrand 80
Not applicableTemporarily pausedNCT03074812
What this trial is testing

Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation

Who this might be right for
Idiopathic Parkinson's DiseaseParkinson DiseaseDepression
Johns Hopkins University 80
Not applicableStudy completedNCT00368199
What this trial is testing

Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes

Who this might be right for
Parkinson's DiseaseParkinsonian SyndromeMultiple System Atrophy+4 more
Maastricht University Medical Center 196
Early research (Phase 1)Study completedNCT02611167
What this trial is testing

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
The University of Texas Health Science Center, Houston 20
Early research (Phase 1)Study completedNCT00115427
What this trial is testing

Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Amgen
Testing effectiveness (Phase 2)Study completedNCT03257046
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease

Who this might be right for
Parkinson Disease
Intra-Cellular Therapies, Inc. 40
Not applicableLooking for participantsNCT06859528
What this trial is testing

Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinson Disease, Idiopathic
St. Louis University 40
Post-approval studies (Phase 4)Study completedNCT01711866
What this trial is testing

A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease

Who this might be right for
Advanced Idiopathic Parkinson's Disease
UCB BIOSCIENCES GmbH 87
Not applicableStudy completedNCT01536769
What this trial is testing

Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
Helsinki University Central Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00239564
What this trial is testing

Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Impax Laboratories, LLC 12
Large-scale testing (Phase 3)Study completedNCT01968031
What this trial is testing

A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Kyowa Kirin Co., Ltd. 613
Testing effectiveness (Phase 2)Ended earlyNCT01789047
What this trial is testing

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's DiseaseDrug Induced Dyskinesia
Rush University Medical Center 42
Next Page